2019
Adipokine gene variability and plasma levels in patients with chronic periodontitis - a case-control study
BOŘILOVÁ LINHARTOVÁ, Petra, Július JÁNOŠ, Hana POSKEROVÁ, Denisa KAVŘÍKOVÁ, Antonín FASSMANN et. al.Základní údaje
Originální název
Adipokine gene variability and plasma levels in patients with chronic periodontitis - a case-control study
Autoři
BOŘILOVÁ LINHARTOVÁ, Petra (203 Česká republika, domácí), Július JÁNOŠ (703 Slovensko, domácí), Hana POSKEROVÁ (203 Česká republika, domácí), Denisa KAVŘÍKOVÁ (203 Česká republika, domácí), Antonín FASSMANN (203 Česká republika, domácí), Ladislav DUŠEK (203 Česká republika, domácí) a Lydie IZAKOVIČOVÁ HOLLÁ (203 Česká republika, garant, domácí)
Vydání
BRAZILIAN ORAL RESEARCH, SAO PAULO, SOCIEDADE BRASILEIRA DE PESQUISA ODONTOLOGICA, 2019, 1807-3107
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30208 Dentistry, oral surgery and medicine
Stát vydavatele
Brazílie
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.633
Kód RIV
RIV/00216224:14110/19:00107509
Organizační jednotka
Lékařská fakulta
UT WoS
000468342300001
Klíčová slova anglicky
Chronic Periodontitis; Diabetes Mellitus; Type 2; Adipokines
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 29. 4. 2020 07:46, Mgr. Tereza Miškechová
Anotace
V originále
Specific variants in genes that encode adipokines and their mRNA and protein expression were previously studied in type 2 diabetes mellitus (T2DM) and obesity, and similar studies have been performed for chronic periodontitis (CP). The aim of this case-control study was to investigate the possible impacts of adiponectin (ADIPOQ), leptin (LEP) and its receptor (LEPR), and resistin (RETN) on the etiopathogenesis of CP. Examinations were performed on 118 non-periodontitis healthy subjects (healthy controls, HC), 205 healthy individuals with CP (H + CP) and 86 type 2 diabetes patients with CP (T2DM + CP). Variants within the ADIPOQ (rs2241766, rs1501299), LEP (rs13228377, rs2167270), LEP receptor (rs1805096), and RETN (rs1862513) genes were determined by qPCR. In addition, the plasma levels of ADIPOQ, LEP, and RETN were analysed by ELISA for 80 individuals. The genotype frequencies of the SNP ADIPOQ + 45G/T (rs2241766) differed between the HC and H + CP groups (p=0.03, p(corr)>0.05), and carriers of the TT genotype had a lower risk of developing CP compared to carriers of the GG or TG genotypes (p<0.01, p(corr)>0.05). However, there were no significant differences in the plasma levels of ADIPOQ, LEP or RETN between the study groups (p > 0.05). Plasma levels of the adipokines were also independent of the gene profiles (p > 0.05). Adipokine plasma levels did not change in patients with H + CP/T2DM + CP compared to HC, but we did identify a specific polymorphism in the ADIPOQ gene that was associated with CP. Although the ADIPOQ + 45G/T (rs2241766) gene variant may be a candidate biomarker for CP, further research is required in larger populations with different ethnic backgrounds before any final conclusions can be drawn about the role of this gene in CP.
Návaznosti
GB14-37368G, projekt VaV |
| ||
MUNI/A/1008/2017, interní kód MU |
| ||
MUNI/A/1546/2018, interní kód MU |
| ||
ROZV/25/LF/2017, interní kód MU |
|